CD4 and AIDS: However, patients receiving InSTI‐based regimens had less severe disease, indicated by fewer baseline AIDS diagnoses (CD4 < 200/mm3 or CDC stage C) and lower HIV RNA levels than those on PI‐based and NNRTI‐based regimens.